SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-22-006009
Filing Date
2022-04-22
Accepted
2022-04-22 16:05:23
Documents
6
Period of Report
2022-06-16

Document Format Files

Seq Description Document Type Size
1 DEF 14A fstx_def_14a.htm DEF 14A 936358
2 GRAPHIC img226560310_0.jpg GRAPHIC 92197
3 GRAPHIC img226560310_1.jpg GRAPHIC 17040
4 GRAPHIC img226560310_2.jpg GRAPHIC 16328
5 GRAPHIC img226560310_3.jpg GRAPHIC 118879
6 GRAPHIC img226560310_4.jpg GRAPHIC 93554
  Complete submission text file 0000950170-22-006009.txt   1392650
Mailing Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT
Business Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT 44 1223 497400
F-star Therapeutics, Inc. (Filer) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37718 | Film No.: 22845482
SIC: 2834 Pharmaceutical Preparations